COVID-19 Clinical Trial

The trial aims to enroll the person diagnosed with COVID-19 (index patient) and any unvaccinated adults who are not COVID-19 positive and are not experiencing COVID-19 symptoms.

Trial eligibility

The trial aims to enroll the person diagnosed with COVID-19 (index patient) and any unvaccinated adults who are not COVID-19 positive and are not experiencing COVID-19 symptoms.

Household members may be eligible to enroll in the MOVe-AHEAD study if:

Index patient: A person (any age) that has been diagnosed as COVID-19 positive in the past 5 days. The Index case will not receive any study drug or currently approved treatments as part of the trial.

Primary participant: Unvaccinated adults who are not experiencing COVID-19 symptoms and are not currently COVID-19 positive that live with the index patient. These participants will be randomized to either study drug or placebo.

For more info please contact: 786-772-0510

Location:
Hialeah, FL
Call us:
786-772-0510
Skip to content